New work presented at the 2024 congress of EULAR—The European Alliance of Associations for Rheumatology—assesses the power of multi-modal analysis of synovial tissue inflammation in treatment-naïve patients with rheumatoid arthritis (RA). The hope is to identify predictive biomarkers for treatment response.
This article was originally published on MedicalXpress.com